Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McConkey

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
British Journal of Rheumatology|August 1, 1987
Rheumatoid arthritis and IgA nephropathyM Beaman, D Adu, A J Howie, et al.
British Journal of Rheumatology|May 1, 1985
Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugsK A Grindulis, D L Scott, M W Robinson, et al.
British Journal of Cancer|April 1, 1981
Serum proteins as tumour markers for breast cancerP Mattison, D H Cove, L Walsh, et al.
British Medical Journal|February 16, 1980
Sulphasalazine in rheumatoid arthritisB McConkey, R S Amos, S Durham, et al.
The Science of the Total Environment|October 19, 2020
Influence of two management practices in the Canadian Prairies on radiative forcingJ Liu, D E Worth, R L Desjardins, et al.
Rheumatology and Rehabilitation|August 1, 1976
Dapsone in rheumatoid arthritisB McConkey, P Davies, R A Crockson, et al.
Lancet (London, England)|January 11, 1986
Non-steroidal anti-inflammatory drugs and renal failureD H Adams, A J Howie, J Michael, et al.
British Medical Journal (Clinical Research Ed.)|August 16, 1986
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 yearsR S Amos, T Pullar, D E Bax, et al.
Annals of the Rheumatic Diseases|February 1, 1991
Chain breaking antioxidant status in rheumatoid arthritis: clinical and laboratory correlatesR D Situnayake, D I Thurnham, S Kootathep, et al.
Scandinavian Journal of Rheumatology|January 1, 1983
A comparison between clinical and laboratory tests in rheumatoid arthritisK A Grindulis, M Calverley, T J Constable, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
British Journal of Rheumatology|August 1, 1987
Rheumatoid arthritis and IgA nephropathyM Beaman, D Adu, A J Howie, et al.
British Journal of Rheumatology|May 1, 1985
Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugsK A Grindulis, D L Scott, M W Robinson, et al.
British Journal of Cancer|April 1, 1981
Serum proteins as tumour markers for breast cancerP Mattison, D H Cove, L Walsh, et al.
British Medical Journal|February 16, 1980
Sulphasalazine in rheumatoid arthritisB McConkey, R S Amos, S Durham, et al.
The Science of the Total Environment|October 19, 2020
Influence of two management practices in the Canadian Prairies on radiative forcingJ Liu, D E Worth, R L Desjardins, et al.
Rheumatology and Rehabilitation|August 1, 1976
Dapsone in rheumatoid arthritisB McConkey, P Davies, R A Crockson, et al.
Lancet (London, England)|January 11, 1986
Non-steroidal anti-inflammatory drugs and renal failureD H Adams, A J Howie, J Michael, et al.
British Medical Journal (Clinical Research Ed.)|August 16, 1986
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 yearsR S Amos, T Pullar, D E Bax, et al.
Annals of the Rheumatic Diseases|February 1, 1991
Chain breaking antioxidant status in rheumatoid arthritis: clinical and laboratory correlatesR D Situnayake, D I Thurnham, S Kootathep, et al.
Scandinavian Journal of Rheumatology|January 1, 1983
A comparison between clinical and laboratory tests in rheumatoid arthritisK A Grindulis, M Calverley, T J Constable, et al.
Pageof 7